In a critical public health alert, the Drug Regulatory Authority of Pakistan (DRAP) has ordered the immediate recall of three substandard syringes following alarming test results from the Central Drugs Laboratory Karachi.
Faulty Syringes Identified
The recalled products include:
- Zindagi Auto Disable Syringe 5ml – failed sterility test
- Ultra Fine SMD Painless Syringe 5ml & 3ml – failed sterility and description tests, with visible black particles found in the barrel.
Health Risks
DRAP warned that using these syringes in invasive or intravenous procedures could introduce microbial contaminants, leading to localized infections, abscesses, or life-threatening systemic infections, especially in immunocompromised patients.
Immediate Action Required
Pharmacists, chemists, and distributors have been instructed to:
- Stop supplying the affected products
- Quarantine remaining stocks
- Return them to suppliers or manufacturers
Consumers are advised to discontinue use and consult healthcare providers if they experience any adverse effects. DRAP has also urged the public to report incidents through its National Pharmacovigilance Centre.
Regulatory Oversight
This recall is part of DRAP’s ongoing efforts to strengthen medical product safety in Pakistan. Similar actions were taken in 2024 and 2023 involving contaminated syrups and injections.
+ There are no comments
Add yours